(Q44597940)

4 December 2017

title

The metabolic syndrome: a critical appraisal based on the CUORE epidemiologic study (English)

1 reference

4 December 2017

1 reference

Paolo Chiodini

10

0 references

Amalia Mattiello

object named as

Amalia Mattiello

9

0 references

Jeremiah Stamler

2

object named as

Jeremiah Stamler

1 reference

4 December 2017

4

Salvatore Panico

1 reference

4 December 2017

7

Giuseppe Mancia

1 reference

4 December 2017

Simona Giampaoli

1

1 reference

4 December 2017

Chiara Donfrancesco

3

1 reference

4 December 2017

Diego Vanuzzo

5

1 reference

4 December 2017

Giancarlo Cesana

6

1 reference

4 December 2017

Lorenza Pilotto

8

1 reference

4 December 2017

Luigi Palmieri

11

1 reference

4 December 2017

Progetto CUORE Research Group

12

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 April 2009

1 reference

4 December 2017

1 reference

4 December 2017

volume

48

1 reference

4 December 2017

issue

6

1 reference

4 December 2017

page(s)

525-531

1 reference

Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

Advances in statistical methodology for the evaluation of diagnostic and laboratory tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

Plasma glucose levels: long-term effect of diet in the Chicago Coronary Prevention Evaluation Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

Favorable Cardiovascular Risk Profile (Low Risk) and 10-Year Stroke Incidence in Women and Men: Findings from 12 Italian Population Samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

The relationship of weight change to changes in blood pressure, serum uric acid, cholesterol and glucose in the treatment of hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

Metabolic syndrome, low-density lipoprotein cholesterol, and risk of cardiovascular disease: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

Consistently stable or decreased body mass index in young adulthood and longitudinal changes in metabolic syndrome components: the Coronary Artery Risk Development in Young Adults Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: results of a 15 years follow-up in a Mediterranean population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels--a prospective and cross-sectional evaluation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

Favorable cardiovascular risk profile and 10-year coronary heart disease incidence in women and men: results from the Progetto CUORE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

Preventive potential of body mass reduction to lower cardiovascular risk: The Italian Progetto CUORE study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

Clustering of metabolic factors and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

Is metabolic syndrome a discrete entity in the general population? Evidence from the Caerphilly and Speedwell population studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2009.03.017

10.1016/J.YPMED.2009.03.017

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference